Sunita K. C. Basnet

447 citations

19 papers · 368 indexed · h-index 11

Co-authors: Shudong Wang Mingfeng Yu Hugo Albrecht Theodosia Teo Sarah Diab Robert Milne Matthew J. Sykes Frankie Lam
Topics: Advanced Breast Cancer Therapies (7 papers)PI3K/AKT/mTOR signaling in cancer (7 papers)Cancer-related Molecular Pathways (6 papers)
Cited by: Hematology Genetics Organic Chemistry
Journals: Journal of Medicinal Chemistry Molecules Molecular Pharmacology
Partner nations: Australia China

In The Last Decade

Sunita K. C. Basnet

17 papers receiving 363 citations

Peers

Countries citing papers authored by Sunita K. C. Basnet

Since Specialization

Citations

This map shows the geographic impact of Sunita K. C. Basnet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunita K. C. Basnet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunita K. C. Basnet more than expected).

Fields of papers citing papers by Sunita K. C. Basnet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sunita K. C. Basnet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunita K. C. Basnet. The network helps show where Sunita K. C. Basnet may publish in the future.

Co-authorship network of co-authors of Sunita K. C. Basnet

This figure shows the co-authorship network connecting the top 25 collaborators of Sunita K. C. Basnet. A scholar is included among the top collaborators of Sunita K. C. Basnet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sunita K. C. Basnet. Sunita K. C. Basnet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	A brain-penetrant CDK4/6 inhibitor - AU3-14 shows robust anti-tumor efficacy against glioblastoma 2025 ·Biomedicine & Pharmacotherapy ·Laychiluh Mekonnen,Theodosia Teo,Benjamin Noll,(unknown),(unknown),Sunita K. C. Basnet,(unknown),Robert Milne,Briony L. Gliddon,Melinda N. Tea,Stuart M. Pitson,Yan Zhou,Lijun Wei,Hui Wang,Jun Liu,Xiang Zhou,Ke Wang,Shudong Wang	0
2	A novel CDK4 inhibitor for myeloid protection in chemotherapy-treated triple-negative breast Cancer 2025 ·Investigational New Drugs ·Ava Safaroghli‐Azar,Laychiluh Mekonnen,(unknown),(unknown),Sunita K. C. Basnet,(unknown),(unknown),Shudong Wang	0
3	Discovery of N,4-Di(1H-pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and Evaluation 2023 ·Molecules ·(unknown),(unknown),Theodosia Teo,(unknown),Laychiluh Mekonnen,Yuchao Yang,Sunita K. C. Basnet,(unknown),Matthew J. Sykes,Mingfeng Yu,Shudong Wang	6
4	2-Anilino-4-(1-methyl-1H-pyrazol-4-yl)pyrimidine-derived CDK2 inhibitors as anticancer agents: Design, synthesis & evaluation 2023 ·Bioorganic & Medicinal Chemistry ·(unknown),Laychiluh Mekonnen,Sunita K. C. Basnet,Theodosia Teo,(unknown),(unknown),(unknown),Solomon Tadesse,Matthew J. Sykes,Mingfeng Yu,Shudong Wang	13
5	An Orally Bioavailable and Highly Efficacious Inhibitor of CDK9/FLT3 for the Treatment of Acute Myeloid Leukemia 2022 ·Cancers ·Abel Tesfaye Anshabo,(unknown),Sarah Diab,(unknown),(unknown),Long Yi,(unknown),(unknown),Benjamin Noll,Sunita K. C. Basnet,Manjun Li,Robert Milne,Hugo Albrecht,Shudong Wang	10
6	Discovery of Potent Inhibitors of Cyclin‐Dependent Kinases 7 and 9: Design, Synthesis, Structure‐Activity Relationship Analysis and Biological Evaluation 2022 ·ChemMedChem ·Renjie Chen,(unknown),Long Yi,Sunita K. C. Basnet,Theodosia Teo,Yuchao Yang,Laychiluh Mekonnen,Mingfeng Yu,Shudong Wang	4
7	Discovery of novel 4-azaaryl-N-phenylpyrimidin-2-amine derivatives as potent and selective FLT3 inhibitors for acute myeloid leukaemia with FLT3 mutations 2021 ·European Journal of Medicinal Chemistry ·Long Yi,Mingfeng Yu,(unknown),(unknown),Sunita K. C. Basnet,(unknown),(unknown),Shudong Wang	10
8	Discovery of CDK5 Inhibitors through Structure-Guided Approach 2019 ·ACS Medicinal Chemistry Letters ·(unknown),(unknown),Solomon Tadesse,Malika Kumarasiri,Sunita K. C. Basnet,Laychiluh Mekonnen,Manjun Li,Sarah Diab,Matthew J. Sykes,Hugo Albrecht,Robert Milne,Shudong Wang	21
9	Synthesis and evaluation of 2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione derivatives as Mnk inhibitors 2019 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Sunita K. C. Basnet,(unknown),Manjun Li,Solomon Tadesse,Hugo Albrecht,Cobus Gerber,Mingfeng Yu,Shudong Wang	10
10	Discovery of N-Phenyl-4-(1H-pyrrol-3-yl)pyrimidin-2-amine Derivatives as Potent Mnk2 Inhibitors: Design, Synthesis, SAR Analysis, and Evaluation of in vitro Anti-leukaemic Activity 2018 ·Medicinal Chemistry ·(unknown),Sarah Diab,(unknown),Sunita K. C. Basnet,Benjamin Noll,Peng Li,Laychiluh Mekonnen,Jingfeng Lu,Hugo Albrecht,Robert Milne,Cobus Gerber,Mingfeng Yu,Shudong Wang	5
11	Dual Inhibition of Mnk2 and FLT3 for potential treatment of acute myeloid leukaemia 2017 ·European Journal of Medicinal Chemistry ·Sarah Diab,(unknown),Peng Li,Theodosia Teo,Sunita K. C. Basnet,(unknown),(unknown),Jingfeng Lu,Jinqiang Hou,Mingfeng Yu,(unknown),Hugo Albrecht,Robert Milne,Shudong Wang	23
12	Highly Potent, Selective, and Orally Bioavailable 4-Thiazol-N-(pyridin-2-yl)pyrimidin-2-amine Cyclin-Dependent Kinases 4 and 6 Inhibitors as Anticancer Drug Candidates: Design, Synthesis, and Evaluation 2017 ·Journal of Medicinal Chemistry ·Solomon Tadesse,Mingfeng Yu,Laychiluh Mekonnen,Frankie Lam,(unknown),(unknown),(unknown),Benjamin Noll,Sunita K. C. Basnet,Theodosia Teo,Hugo Albrecht,Robert Milne,Shudong Wang	61
13	Unveiling New Chemical Scaffolds as Mnk Inhibitors 2016 ·Future Medicinal Chemistry ·Sarah Diab,Peng Li,Sunita K. C. Basnet,Jingfeng Lu,Mingfeng Yu,Hugo Albrecht,Robert Milne,Shudong Wang	17
14	Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cells 2016 ·Oncotarget ·Peng Li,Sarah Diab,Mingfeng Yu,Julian Adams,(unknown),Sunita K. C. Basnet,Hugo Albrecht,Robert Milne,Shudong Wang	22
15	Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure–activity relationship analysis and biological evaluation 2015 ·European Journal of Medicinal Chemistry ·Mingfeng Yu,(unknown),Sunita K. C. Basnet,Malika Kumarasiri,Sarah Diab,Theodosia Teo,Hugo Albrecht,Shudong Wang	31
16	An integrated approach for discovery of highly potent and selective Mnk inhibitors: Screening, synthesis and SAR analysis 2015 ·European Journal of Medicinal Chemistry ·Theodosia Teo,Yuchao Yang,Mingfeng Yu,Sunita K. C. Basnet,(unknown),Jinqiang Hou,Raffaella M. Schmid,Malika Kumarasiri,Sarah Diab,Hugo Albrecht,Matthew J. Sykes,Shudong Wang	23
17	Identification of a Highly Conserved Allosteric Binding Site on Mnk1 and Mnk2 2015 ·Molecular Pharmacology ·Sunita K. C. Basnet,Sarah Diab,Raffaella M. Schmid,Mingfeng Yu,Yuchao Yang,(unknown),Theodosia Teo,Peng Li,Thomas S. Peat,Hugo Albrecht,Shudong Wang	14
18	Pharmacologic Inhibition of MNKs in Acute Myeloid Leukemia 2015 ·Molecular Pharmacology ·Theodosia Teo,Frankie Lam,Mingfeng Yu,Yuchao Yang,Sunita K. C. Basnet,Hugo Albrecht,Matthew J. Sykes,Shudong Wang	27
19	Discovery of 5‐(2‐(Phenylamino)pyrimidin‐4‐yl)thiazol‐2(3H)‐one Derivatives as Potent Mnk2 Inhibitors: Synthesis, SAR Analysis and Biological Evaluation 2014 ·ChemMedChem ·Sarah Diab,Theodosia Teo,Malika Kumarasiri,Peng Li,Mingfeng Yu,Frankie Lam,Sunita K. C. Basnet,Matthew J. Sykes,Hugo Albrecht,Robert Milne,Shudong Wang	71

About Sunita K. C. Basnet

Sunita K. C. Basnet is a scholar working on Genetics, Hematology and Oncology, having authored 19 papers that have together received 368 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (7 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Cancer-related Molecular Pathways (6 papers). The work is most often cited by research in Hematology (53 citations), Genetics (48 citations) and Organic Chemistry (123 citations). Sunita K. C. Basnet has collaborated with scholars based in Australia and China. Frequent co-authors include Shudong Wang, Mingfeng Yu, Hugo Albrecht, Theodosia Teo, Sarah Diab, Robert Milne, Matthew J. Sykes, Frankie Lam, Malika Kumarasiri and Peng Li. Their work appears in journals such as Journal of Medicinal Chemistry, Molecules and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact